EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT BETWEEN LES LABORATOIRES SERVIER SAS INSTITUT DE RECHERCHES INTERNATIONALES SERVIER SAS AND PFIZER INC.Exclusive License and Collaboration Agreement • September 17th, 2018 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Exclusive License and Collaboration Agreement is entered into as of the 30 day of October, 2015 (the “Signing Date”) by and between Les Laboratoires Servier, a corporation incorporated under the laws of France having a principal place of business at 50 rue Carnot, 92150 Suresnes, France (“LLS”) and Institut de Recherches Internationales Servier, a corporation incorporated under the laws of France having its principal place of business at 50 rue Carnot, 92150 Suresnes, France (“IRIS”) (LLS and IRIS being together referred to as “Servier”), and Pfizer Inc., a Delaware corporation having its principal place of business at 235 E. 42nd Street, New York, New York 10017 (“Pfizer”). Servier and Pfizer are individually referred to herein as a “Party” and collectively, as the “Parties”.
